Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Moonlake Immunotherapeutics (MLTX)

Moonlake Immunotherapeutics (MLTX)
43.14 x 2 43.40 x 9
Post-market by (Cboe BZX)
43.23 -0.84 (-1.91%) 02/11/25 [NASDAQ]
43.14 x 2 43.40 x 9
Post-market 43.23 unch (unch) 16:01 ET
Quote Overview for Tue, Feb 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
42.65
Day High
43.94
Open 43.50
Previous Close 44.07 44.07
Volume 173,531 173,531
Avg Vol 483,662 483,662
Stochastic %K 23.62% 23.62%
Weighted Alpha -25.21 -25.21
5-Day Change -0.88 (-2.00%) -0.88 (-2.00%)
52-Week Range 37.55 - 64.98 37.55 - 64.98
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,816,293
  • Shares Outstanding, K 63,905
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,010 K
  • EBIT $ -109 M
  • EBITDA $ -109 M
  • 60-Month Beta 1.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.81

Options Overview Details

View History
  • Implied Volatility 66.76% ( -0.41%)
  • Historical Volatility 51.15%
  • IV Percentile 65%
  • IV Rank 24.17%
  • IV High 128.64% on 02/12/24
  • IV Low 47.04% on 11/25/24
  • Put/Call Vol Ratio 1.50
  • Today's Volume 5
  • Volume Avg (30-Day) 118
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 2,963
  • Open Int (30-Day) 3,092

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.63
  • Number of Estimates 8
  • High Estimate -0.45
  • Low Estimate -0.76
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -425.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.27 +4.75%
on 01/16/25
Period Open: 46.31
49.06 -11.88%
on 01/15/25
-3.08 (-6.66%)
since 01/10/25
3-Month
41.27 +4.75%
on 01/16/25
Period Open: 53.89
58.26 -25.80%
on 12/17/24
-10.66 (-19.78%)
since 11/11/24
52-Week
37.55 +15.13%
on 06/24/24
Period Open: 63.19
64.98 -33.47%
on 02/12/24
-19.96 (-31.59%)
since 02/09/24

Most Recent Stories

More News
Goldman Sachs Thinks Mid-Cap Biotech MoonLake Could Soar Over 80%: Is Retail Watching Closely?

Oppenheimer has included MoonLake among its top biotech picks for 2025, alongside Capricor, Gilead, Kymera, Praxis, and Prothena.

GURU : 53.21 (-0.33%)
GDOC : 33.88 (-0.58%)
SBIO : 31.69 (-1.55%)
MLTX : 43.23 (-1.91%)
Will this year's top performing stock ETFs stay hot in '24?

Even if there is a clear market rotation, these top performing ETFs will have an opportunity to secure gains and move on to be potential trophy winners in 2024.

ARKK : 61.35 (-2.18%)
FBCG.BZ : N/A (N/A)
VCAR : 23.85 (-1.81%)
COIN : 266.90 (-4.75%)
ROKU : 82.75 (-2.19%)
META : 719.80 (+0.33%)
PLTR : 112.62 (-3.45%)
SHOP : 123.59 (+3.08%)
NVDA : 132.80 (-0.58%)
UBER : 76.95 (-2.14%)
ANF : 109.42 (-3.33%)
DKNG : 43.44 (+1.40%)
Why Shares of MoonLake Immunotherapeutics Are Rising Tuesday

A competitor's clinical trial stumble may be benefiting MoonLake.

SLRN : 2.0300 (+7.41%)
MLTX : 43.23 (-1.91%)
MarketBeat Week in Review – 6/26 - 6/30

Markets headed into a holiday week cheering a lower-than-expected key inflation reading, but investors should expect volatility in a short trading week.

NIO : 4.04 (-6.70%)
FROG : 35.95 (-1.61%)
MLTX : 43.23 (-1.91%)
MDB : 286.12 (-0.08%)
SHW : 361.37 (+0.62%)
GIS : 59.35 (+2.19%)
MULN : 0.2575 (+13.94%)
AAPL : 232.62 (+2.18%)
GOOGL : 185.32 (-0.62%)
LCID : 2.69 (-2.89%)
KFY : 68.18 (+0.72%)
META : 719.80 (+0.33%)
Why MoonLake Immunotherapeutics Stock Skyrocketed This Week

Positive mid-stage results fueled a spike in the biotech's shares this week.

MLTX : 43.23 (-1.91%)
MoonLake Immunotherapeutics Makes a Moonshot on Trials

Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.

MLTX : 43.23 (-1.91%)
IMGN : 31.23 (unch)
Why MoonLake Immunotherapeutics Was Such a Healthy Stock Today

The heavily bullish sentiment on the company only grew on the second trading day of the week.

BCS : 15.23 (+1.67%)
MLTX : 43.23 (-1.91%)
Why Shares of MoonLake Immunotherapeutics Skyrocketed Monday

The company reported positive phase 2 clinical trial results.

MLTX : 43.23 (-1.91%)
MoonLake Immunotherapeutics (NASDAQ: MLTX) Announces Breakthrough Results for Sonelokimab in Phase 2 Trial

MoonLake Immunotherapeutics (NASDAQ: MLTX) has made significant strides with the successful outcome of their Phase 2 MIRA trial for sonelokimab,

MLTX : 43.23 (-1.91%)
Lucid Stock Moved Into the Fast Lane, but This Nasdaq Biotech Was Monday's Big Winner

Markets looked poised to start the new week flat.

COMP : 7.44 (+0.81%)
$NASX : 19,643.86 (-0.36%)
LCID : 2.69 (-2.89%)
MLTX : 43.23 (-1.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

See More

Key Turning Points

3rd Resistance Point 45.19
2nd Resistance Point 44.56
1st Resistance Point 43.90
Last Price 43.23
1st Support Level 42.61
2nd Support Level 41.98
3rd Support Level 41.32

See More

52-Week High 64.98
Fibonacci 61.8% 54.50
Fibonacci 50% 51.26
Fibonacci 38.2% 48.03
Last Price 43.23
52-Week Low 37.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Optimizing Trade Entries with the Futures Trading Guide